For Purchasing Managers, Technical Directors, and Operations Leaders who demand consistent potency, regulatory compliance, and rapid delivery at competitive cost.
Get Free Quote in 24 hIn 2025‑2026, the global market for Semaglutide (CAS 178243‑46‑4) has surged by over 42 %, driven by expanding indications in diabetes, obesity, and emerging peptide‑based therapeutics. Yet many corporate buyers still encounter the same three critical bottlenecks:
Case in point: A U.S. biotech firm reported a 37 % cost increase after switching to a low‑cost Asian vendor that failed to meet FDA‑listed specifications, forcing a costly re‑validation cycle.
What does this mean for you? Every extra dollar or week of delay erodes ROI, jeopardizes clinical timelines, and can jeopardize regulatory approval.
Global Technology Co., Ltd leverages a state‑of‑the‑art GMP‑certified facility partnered with leading Chinese universities and FDA‑approved laboratories. Our CAS 178243‑46‑4 Semaglutide is produced under a strict 5‑step purification protocol, guaranteeing > 99.9 % purity, ≥ 98 % assay potency, and full compliance with USP‑Ph. Eur. standards.
| Parameter | Value | Unit | Compliance |
|---|---|---|---|
| CAS Number | 178243‑46‑4 | ‑ | USP, EP |
| Purity (HPLC) | ≥ 99.9 | % | ISO 9001, GMP |
| Assay | ≥ 98.0 | % | FDA, EMA |
| Moisture Content | ≤ 0.5 | % | Ph. Eur. |
| Particle Size | < 200 µm | µm | ISO 2768 |
| Shelf Life | 24 | Months | - |
Clinical Development – A Phase II obesity trial in Boston reduced API spend by 28 % after switching to our bulk‑grade Semaglutide, while maintaining assay integrity for 12 months of stability testing.
Contract Manufacturing – An outsourced GMP facility in New Jersey sourced 2 tonnes of our Semaglutide for a GLP‑1 analog pipeline, achieving a 35 % faster batch release due to our low‑moisture, high‑solubility material.
Research & Early‑Stage Discovery – University labs in the UK reported a 15 % increase in cell‑assay reproducibility after using our certificate‑backed product versus a generic supplier.
Our standard MOQ is **1 kg** for bulk orders. For research‑grade quantities, we can supply as low as **10 g** with a fast‑track sample program.
Yes. Our ODM service includes custom analogues, ^13C/^15N labeling, and bulk‑scale synthesis. Lead time for custom projects is typically **3‑4 weeks** after final specification approval.

All shipments include a **DMF‑style dossier**, full **Certificate of Analysis**, and **FDA‑compliant packaging**. We also provide a **customs brokerage service** at no extra charge to guarantee smooth clearance.
First‑time customers can use **T/T 30 % upfront, 70 % upon B/L** or **L/C at sight**. For qualified long‑term partners, we offer **net‑30** or **net‑60** after a successful trial order.
All Semaglutide batches are packed in **cold‑chain containers (2‑8 °C)** with real‑time temperature data loggers. This ensures product integrity throughout the journey.
Our technical team offers **24/7 email support**, on‑site analytical verification (if required), and a **30‑day product guarantee** – replace any batch that fails to meet the agreed specifications.
Limited‑time offer: **Free 5 g sample** + **30 % discount on your first 5 kg order** – valid until 30 June 2026. Stock is limited due to high demand.
All transactions are covered by our **Money‑Back Guarantee** if the material does not meet the agreed specifications.
James Patel, Procurement Lead – Medix Corp.
Sophie Liu, R&D Scientist – Oxford Biotech
Michael O’Connor, Operations Manager – HealthGen Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Trusted by Leading Pharma & Biotech Brands
ACTH-(11-24)-CAS-4237-93-8-research-peptide Amitraz-solution CAS-104486-69-3-Bivalirudin Akt-protein-kinase-b
What Our Partners Say
“Switching to Global Technology’s Semaglutide cut our raw‑material spend by **$150 k** and accelerated IND filing by **6 weeks**. The CoA is flawless and the logistics team handled customs flawlessly.”
“The 48‑hour express shipment saved us from a critical stock‑out during our Phase III trial. Quality was exactly as promised – no deviation in assay.”
“Our peptide‑binding assays showed **15 % lower variance** when using the GMP‑grade Semaglutide from Global Technology versus the previous vendor.”
Certificates & Compliance